HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Ru Huang Selected Research

NF-kappa B (NF-kB)

1/2021Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice.
1/2020Long Non-coding RNA LRNA9884 Promotes Acute Kidney Injury via Regulating NF-kB-Mediated Transcriptional Activation of MIF.
1/2011Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.
6/2007Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Ru Huang Research Topics

Disease

25Fibrosis (Cirrhosis)
01/2022 - 06/2007
20Inflammation (Inflammations)
12/2021 - 07/2004
7Neoplasms (Cancer)
01/2022 - 01/2011
7Chronic Renal Insufficiency
01/2022 - 05/2015
7Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 06/2015
4Ureteral Obstruction
01/2022 - 01/2018
4Heart Diseases (Heart Disease)
09/2020 - 05/2003
4Kidney Diseases (Kidney Disease)
01/2020 - 06/2007
4Necrosis
10/2018 - 06/2015
3Melanoma (Melanoma, Malignant)
03/2021 - 01/2018
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 06/2015
3Acute Kidney Injury (Acute Renal Failure)
01/2020 - 01/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2020
2Wounds and Injuries (Trauma)
01/2022 - 06/2015
2Carcinoma (Carcinomatosis)
03/2021 - 01/2018
2Neoplasm Metastasis (Metastasis)
03/2021 - 01/2011
2Hypertensive Nephropathy
11/2020 - 10/2017
2Hypertension (High Blood Pressure)
11/2020 - 05/2014
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2011
2Glomerulonephritis
01/2017 - 06/2007
2Peritoneal Fibrosis
09/2014 - 08/2014
2Infections
06/2005 - 07/2004
2Atherosclerotic Plaque (Atheroma)
01/2005 - 01/2005
2Atherosclerosis
01/2005 - 01/2005
1Myocardial Infarction
01/2022
1Proteinuria
01/2022
1Glucose Intolerance
01/2022
1Vascular System Injuries
12/2021
1COVID-19
01/2021
1Cytokine Release Syndrome
01/2021
1Critical Illness (Critically Ill)
01/2021
1Renal Insufficiency (Renal Failure)
01/2021

Drug/Important Bio-Agent (IBA)

12Transforming Growth Factors (Transforming Growth Factor)IBA
03/2021 - 05/2014
11CollagenIBA
01/2021 - 06/2007
8CytokinesIBA
01/2020 - 07/2004
7CreatinineIBA
01/2022 - 05/2015
7Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2004
52-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2022 - 02/2016
5Macrophage Migration-Inhibitory FactorsIBA
10/2018 - 05/2003
4Fibronectins (Fibronectin)IBA
01/2021 - 06/2015
4Long Noncoding RNAIBA
01/2021 - 01/2018
4NF-kappa B (NF-kB)IBA
01/2021 - 06/2007
4Angiotensin IIIBA
01/2021 - 05/2014
4C-Reactive ProteinIBA
01/2021 - 01/2016
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2020 - 06/2007
3ChromatinIBA
01/2022 - 01/2018
3Blood Glucose (Blood Sugar)IBA
01/2022 - 06/2015
3Therapeutic UsesIBA
01/2022 - 06/2007
3Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2020
3asiatic acidIBA
03/2021 - 11/2015
3naringeninIBA
03/2021 - 11/2015
3Matrix Metalloproteinases (MMPs)IBA
03/2021 - 01/2005
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
3Transforming Growth Factor beta (TGF-beta)IBA
01/2021 - 06/2007
3InterleukinsIBA
09/2020 - 06/2015
3MicroRNAs (MicroRNA)IBA
01/2020 - 05/2014
3Cisplatin (Platino)FDA LinkGeneric
10/2018 - 01/2017
2Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2017
2UbiquitinIBA
01/2021 - 10/2017
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2018
2AngiotensinsIBA
11/2020 - 10/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 10/2018
2Pattern Recognition ReceptorsIBA
01/2020 - 01/2017
2AlbuminsIBA
01/2020 - 06/2015
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2018 - 06/2007
2SolutionsIBA
02/2017 - 08/2014
2ChemokinesIBA
06/2015 - 06/2007
2mouse MIRN29 microRNAIBA
09/2014 - 05/2014
1BIBP 3226IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1methyl methanethiosulfonate (MMTS)IBA
01/2022
1Insulin (Novolin)FDA Link
01/2022
1Neuropeptide YIBA
01/2022
1Clopidogrel (Plavix)FDA Link
01/2022
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
12/2021
1kallistatinIBA
12/2021
1CateninsIBA
12/2021
1AMY-101IBA
01/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1LinagliptinIBA
01/2021
1Hepatitis A Virus Cellular Receptor 1IBA
01/2021
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Cathepsin BIBA
01/2021
1EnzymesIBA
01/2021
1Proton-Translocating ATPases (ATPase, H+)IBA
01/2021
1ImmunosorbentsIBA
01/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021
1Bovine Serum AlbuminIBA
01/2021
1Advanced Glycation End ProductsIBA
01/2021
1Untranslated Regions (Untranslated Region)IBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021
1Lysosomal-Associated Membrane Protein 1IBA
01/2021
1Cell Adhesion Molecule-1IBA
09/2020

Therapy/Procedure

12Therapeutics
01/2022 - 08/2014
3Peritoneal Dialysis
02/2017 - 08/2014
2Immunotherapy
01/2022 - 01/2018
2Microbubbles
01/2020 - 09/2013
1Transplantation
01/2021